Prucalopride Succinate

琥珀酸普芦卡必利

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NamePrucalopride Succinate
Drug Alias NameRezolor普鲁卡罗酰胺琥珀酸prucalopridum琥珀酸普卢卡必利普卡比利琥珀酸盐 +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsDiabetic GastroparesisEnteral Feeding IntoleranceOpioid-Induced Constipation +[17] 
Global Approved IndicationsConstipation
Approved Indications in ChinaConstipation
Original Approved Country/TerritoryEU
Original Approved Date2009/10/14
Country/TerritoryCzechiaBelgiumBulgaria +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShire Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncTakeda Pharmaceuticals International AG Ireland BranchJanssen Inc +[6] 
Inactive CompaniesShireMovetisNorgine +[11] 
Active IndicationsEnteral Feeding IntoleranceConstipationPostoperative Complications +[4] 
Inactive IndicationsDiabetic GastroparesisOpioid-Induced ConstipationPain +[13] 

Other Information

ATC CodeA06AX05
Related LinksWikipediaDrugBankKEGG